Bristol Myers Squibb Net Income 2006-2021 | BMY

Bristol Myers Squibb annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Bristol Myers Squibb net income for the quarter ending March 31, 2021 was $2.021B, a 360.77% decline year-over-year.
  • Bristol Myers Squibb net income for the twelve months ending March 31, 2021 was $-6.219B, a 751.89% decline year-over-year.
  • Bristol Myers Squibb annual net income for 2020 was $-9.015B, a 362.14% decline from 2019.
  • Bristol Myers Squibb annual net income for 2019 was $3.439B, a 30.1% decline from 2018.
  • Bristol Myers Squibb annual net income for 2018 was $4.92B, a 388.58% increase from 2017.
Bristol Myers Squibb Annual Net Income
(Millions of US $)
2020 $-9,015
2019 $3,439
2018 $4,920
2017 $1,007
2016 $4,457
2015 $1,565
2014 $2,004
2013 $2,563
2012 $1,959
2011 $3,701
2010 $3,090
2009 $10,594
2008 $5,247
2007 $2,165
2006 $1,585
2005 $3,000
Bristol Myers Squibb Quarterly Net Income
(Millions of US $)
2021-03-31 $2,021
2020-12-31 $-10,027
2020-09-30 $1,872
2020-06-30 $-85
2020-03-31 $-775
2019-12-31 $-1,056
2019-09-30 $1,353
2019-06-30 $1,432
2019-03-31 $1,710
2018-12-31 $1,160
2018-09-30 $1,901
2018-06-30 $373
2018-03-31 $1,486
2017-12-31 $-2,328
2017-09-30 $845
2017-06-30 $916
2017-03-31 $1,574
2016-12-31 $894
2016-09-30 $1,202
2016-06-30 $1,166
2016-03-31 $1,195
2015-12-31 $-197
2015-09-30 $706
2015-06-30 $-130
2015-03-31 $1,186
2014-12-31 $13
2014-09-30 $721
2014-06-30 $333
2014-03-31 $937
2013-12-31 $726
2013-09-30 $692
2013-06-30 $536
2013-03-31 $609
2012-12-31 $924
2012-09-30 $-711
2012-06-30 $645
2012-03-31 $1,101
2011-12-31 $850
2011-09-30 $967
2011-06-30 $900
2011-03-31 $984
2010-12-31 $471
2010-09-30 $949
2010-06-30 $927
2010-03-31 $743
2009-12-31 $8,007
2009-09-30 $966
2009-06-30 $983
2009-03-31 $638
2008-12-31 $1,244
2008-09-30 $2,578
2008-06-30 $764
2008-03-31 $661
2007-12-31 $-89
2007-09-30 $858
2007-06-30 $706
2007-03-31 $690
2006-12-31 $-134
2006-09-30 $338
2006-06-30 $667
2006-03-31 $714
2005-12-31 $499
2005-09-30 $964
2005-06-30 $1,004
2005-03-31 $533
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $149.422B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $137.652B 14.85
CSL (CSLLY) Australia $105.792B 0.00
Gilead Sciences (GILD) United States $84.444B 8.99
Moderna (MRNA) United States $79.438B 158.27
Illumina (ILMN) United States $65.030B 93.77
Biogen (BIIB) United States $58.914B 13.48
Regeneron Pharmaceuticals (REGN) United States $55.784B 15.97
BioNTech SE (BNTX) Germany $49.234B 35.70
Vertex Pharmaceuticals (VRTX) United States $48.535B 19.99
Alexion Pharmaceuticals (ALXN) United States $39.905B 15.16
BeiGene (BGNE) Cayman Islands $30.669B 0.00
Genmab (GMAB) Denmark $29.247B 34.28
Seagen (SGEN) United States $27.461B 47.44
Genmab (GNMSF) Denmark $26.920B 6.19
Exact Sciences (EXAS) United States $20.651B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.431B 26.12
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.015B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.783B 0.00
Incyte (INCY) United States $18.280B 36.14
CureVac (CVAC) Germany $17.718B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $17.211B 90.50
ARGENX SE-ADR (ARGX) Netherlands $16.043B 0.00
Zai Lab (ZLAB) China $15.466B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.073B 137.47
Novavax (NVAX) United States $13.058B 0.00
Guardant Health (GH) United States $11.850B 0.00
QIAGEN (QGEN) Netherlands $10.950B 19.44
Repligen (RGEN) United States $10.440B 94.13
CRISPR Therapeutics AG (CRSP) Switzerland $9.389B 0.00
Denali Therapeutics (DNLI) United States $8.921B 320.04
Mirati Therapeutics (MRTX) United States $8.551B 0.00
Fate Therapeutics (FATE) United States $7.772B 0.00
Acceleron Pharma (XLRN) United States $7.693B 0.00
Ascendis Pharma (ASND) Denmark $7.196B 0.00
Exelixis (EXEL) United States $7.029B 112.15
Ultragenyx Pharmaceutical (RARE) United States $6.598B 0.00
Sarepta Therapeutics (SRPT) United States $6.553B 0.00
AbCellera Biologics (ABCL) $6.242B 0.00
Halozyme Therapeutics (HALO) United States $6.137B 33.67
Biohaven Pharmaceutical Holding (BHVN) United States $6.051B 0.00
Vir Biotechnology (VIR) United States $5.780B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.625B 20.38
Intellia Therapeutics (NTLA) United States $5.400B 0.00
Adaptive Biotechnologies (ADPT) United States $5.326B 0.00
Twist Bioscience (TWST) United States $5.230B 0.00
Beam Therapeutics (BEAM) United States $5.223B 0.00
Legend Biotech (LEGN) United States $5.178B 0.00
I-Mab (IMAB) China $5.177B 0.00
Reata Pharmaceuticals (RETA) United States $5.176B 0.00
NeoGenomics (NEO) United States $5.044B 855.40
Galapagos (GLPG) Belgium $4.995B 0.00
Blueprint Medicines (BPMC) United States $4.992B 15.20
Apellis Pharmaceuticals (APLS) United States $4.805B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.149B 0.00
Certara (CERT) United States $4.115B 0.00
Alkermes (ALKS) Ireland $4.026B 0.00
Arvinas (ARVN) United States $4.018B 0.00
Arena Pharmaceuticals (ARNA) United States $3.923B 0.00
SpringWorks Therapeutics (SWTX) United States $3.908B 0.00
Intra-Cellular Therapies (ITCI) United States $3.492B 0.00
Emergent Biosolutions (EBS) United States $3.320B 6.61
Berkeley Lights (BLI) United States $3.115B 0.00
Insmed (INSM) United States $3.001B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.811B 0.00
Vericel (VCEL) United States $2.760B 744.25
Dicerna Pharmaceuticals (DRNA) United States $2.733B 0.00
Amicus Therapeutics (FOLD) United States $2.685B 0.00
MorphoSys AG (MOR) Germany $2.665B 0.00
Prothena (PRTA) Ireland $2.547B 0.00
Sorrento Therapeutics (SRNE) United States $2.501B 0.00
ALX Oncology Holdings (ALXO) United States $2.391B 0.00
Global Blood Therapeutics (GBT) United States $2.382B 0.00
Editas Medicine (EDIT) United States $2.374B 0.00
Morphic Holding (MORF) United States $2.346B 0.00
Myriad Genetics (MYGN) United States $2.321B 0.00
Heska (HSKA) United States $2.304B 1004.59
Instil Bio (TIL) United States $2.240B 0.00
Kymera Therapeutics (KYMR) United States $2.211B 0.00
Bluebird Bio (BLUE) United States $2.211B 0.00
Bionano Genomics (BNGO) United States $2.169B 0.00
Revance Therapeutics (RVNC) United States $2.151B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.143B 0.00
Ligand Pharmaceuticals (LGND) United States $2.085B 34.88
Seer (SEER) $1.957B 0.00
Atea Pharmaceuticals (AVIR) United States $1.943B 0.00
Amarin (AMRN) Ireland $1.930B 0.00
Myovant Sciences (MYOV) United Kingdom $1.927B 0.00
Protagonist Therapeutics (PTGX) United States $1.833B 0.00
Seres Therapeutics (MCRB) United States $1.810B 0.00
Castle Biosciences (CSTL) United States $1.807B 0.00
Inovio Pharmaceuticals (INO) United States $1.795B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.792B 0.00
Alector (ALEC) United States $1.789B 0.00
PHARMA MAR SA (PHMMF) Spain $1.777B 0.00
Zymeworks (ZYME) Canada $1.744B 0.00
Genetron Holdings (GTH) China $1.726B 0.00
Arcus Biosciences (RCUS) United States $1.704B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.658B 0.00
C4 Therapeutics (CCCC) United States $1.647B 0.00
REGENXBIO (RGNX) United States $1.628B 0.00
Sangamo Therapeutics (SGMO) United States $1.620B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.585B 0.00
UniQure (QURE) Netherlands $1.585B 0.00
Cytokinetics (CYTK) United States $1.563B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.559B 0.00
NGM Biopharmaceuticals (NGM) United States $1.506B 0.00
PureTech Health (PRTC) United States $1.506B 0.00
Avid Bioservices (CDMO) United States $1.478B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.446B 0.00
Nurix Therapeutics (NRIX) United States $1.365B 0.00
Precigen (PGEN) United States $1.354B 0.00
BioAtla (BCAB) United States $1.316B 0.00
Northwest Biotherapeutics (NWBO) United States $1.297B 0.00
Ocugen (OCGN) United States $1.290B 0.00
Codexis (CDXS) United States $1.282B 0.00
Zealand Pharma (ZEAL) Denmark $1.282B 0.00
MiMedx (MDXG) United States $1.274B 0.00
Keros Therapeutics (KROS) United States $1.235B 0.00
Repare Therapeutics (RPTX) Canada $1.231B 0.00
Shattuck Labs (STTK) United States $1.169B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.163B 0.00
Prometheus Biosciences (RXDX) United States $1.152B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.148B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
Agenus (AGEN) United States $1.112B 0.00
Celldex Therapeutics (CLDX) United States $1.101B 0.00
Pliant Therapeutics (PLRX) United States $1.090B 0.00
Coherus BioSciences (CHRS) United States $1.087B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.083B 34.19
Scholar Rock Holding (SRRK) United States $1.079B 0.00
MannKind (MNKD) United States $1.079B 0.00
Mesoblast (MESO) Australia $1.060B 0.00
Dynavax Technologies (DVAX) United States $1.015B 0.00
Mersana Therapeutics (MRSN) United States $1.012B 0.00
VBI Vaccines (VBIV) United States $0.999B 0.00
Avidity Biosciences (RNA) United States $0.981B 0.00
Inhibrx (INBX) United States $0.937B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.920B 0.00
G1 THERAPEUTICS (GTHX) United States $0.914B 0.00
Travere Therapeutics (TVTX) United States $0.909B 0.00
Epizyme (EPZM) United States $0.900B 0.00
Cel-Sci (CVM) United States $0.881B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.865B 0.00
Nkarta (NKTX) United States $0.861B 0.00
Sutro Biopharma (STRO) United States $0.844B 0.00
Merus (MRUS) Netherlands $0.803B 0.00
Affimed (AFMD) Germany $0.802B 0.00
Verastem (VSTM) United States $0.801B 0.00
RAPT THERAPTICS (RAPT) United States $0.800B 0.00
Pharming Group (PHAR) Netherlands $0.761B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
SESEN BIO, INC (SESN) United States $0.738B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.736B 0.00
Cara Therapeutics (CARA) United States $0.728B 63.26
IDEAYA Biosciences (IDYA) United States $0.722B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
Kadmon Holdings (KDMN) United States $0.698B 0.00
Curis (CRIS) United States $0.694B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.692B 0.00
DBV Technologies S.A (DBVT) France $0.685B 0.00
AnaptysBio (ANAB) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.678B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.674B 0.00
Clene (CLNN) United States $0.670B 0.00
Cellectis S.A (CLLS) France $0.669B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.665B 0.00
ChromaDex (CDXC) United States $0.664B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
ALBIREO PHARMA (ALBO) United States $0.637B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.627B 0.00
Clovis Oncology (CLVS) United States $0.618B 0.00
Precision BioSciences (DTIL) United States $0.609B 0.00
Anika Therapeutics (ANIK) United States $0.604B 0.00
Adagene (ADAG) China $0.603B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.597B 0.00
Bolt Biotherapeutics (BOLT) United States $0.596B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.593B 0.00
Inventiva S.A (IVA) France $0.587B 0.00
Selecta Biosciences (SELB) United States $0.554B 0.00
Codiak BioSciences (CDAK) United States $0.552B 0.00
AC Immune SA (ACIU) Switzerland $0.538B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.521B 0.00
Compugen (CGEN) Israel $0.520B 0.00
Forte Biosciences (FBRX) United States $0.518B 0.00
Starpharma Holdings (SPHRY) Australia $0.506B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.492B 0.00
XBiotech (XBIT) United States $0.487B 0.00
Gritstone Bio (GRTS) United States $0.477B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.464B 0.00
CytomX Therapeutics (CTMX) United States $0.464B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
Opthea (OPT) Australia $0.450B 0.00
Geron (GERN) United States $0.449B 0.00
Athenex (ATNX) United States $0.448B 0.00
Spero Therapeutics (SPRO) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.433B 0.00
Neoleukin Therapeutics (NLTX) United States $0.426B 0.00
Amryt Pharma (AMYT) United Kingdom $0.423B 0.00
ANI Pharmaceuticals (ANIP) United States $0.423B 11.67
Paratek Pharmaceuticals (PRTK) United States $0.422B 0.00
Kindred Biosciences (KIN) United States $0.418B 0.00
Puma Biotechnology (PBYI) United States $0.417B 0.00
AquaBounty Technologies (AQB) United States $0.413B 0.00
Cue Biopharma (CUE) United States $0.411B 0.00
Angion Biomedica (ANGN) United States $0.393B 0.00
Kala Pharmaceuticals (KALA) United States $0.378B 0.00
SQZ Biotechnologies (SQZ) United States $0.371B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.362B 0.00
UROGEN PHARMA (URGN) United States $0.360B 0.00
Adverum Biotechnologies (ADVM) United States $0.357B 0.00
Cogent Biosciences (COGT) United States $0.353B 0.00
WAVE Life Sciences (WVE) Singapore $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.351B 14.24
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
Fortress Biotech (FBIO) United States $0.346B 0.00
XOMA (XOMA) United States $0.345B 161.26
Athersys (ATHX) United States $0.342B 0.00
Frequency Therapeutics (FREQ) United States $0.341B 0.00
Theratechnologies (THTX) Canada $0.340B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
IBio (IBIO) United States $0.338B 0.00
Cerecor (CERC) United States $0.337B 0.00
Adicet Bio (ACET) United States $0.331B 0.00
Trevena (TRVN) United States $0.327B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.322B 0.00
Innate Pharma S.A (IPHA) France $0.311B 0.00
Arbutus Biopharma (ABUS) United States $0.310B 0.00
CorMedix Inc (CRMD) United States $0.310B 0.00
OVID THERAPEUTC (OVID) United States $0.300B 2.95
Cardiff Oncology (CRDF) United States $0.300B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.279B 0.00
Fulcrum Therapeutics (FULC) United States $0.276B 0.00
Kaleido Biosciences (KLDO) $0.273B 0.00
INmune Bio (INMB) United States $0.266B 0.00
Talis Biomedical (TLIS) United States $0.266B 0.00
Bellus Health (BLU) Canada $0.266B 0.00
Kamada (KMDA) Israel $0.257B 17.49
Seelos Therapeutics (SEEL) United States $0.251B 0.00
HOOKIPA Pharma (HOOK) United States $0.249B 0.00
Chiasma (CHMA) United States $0.240B 0.00
Clearside Biomedical (CLSD) United States $0.235B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
Aptinyx (APTX) United States $0.229B 0.00
NextCure (NXTC) United States $0.227B 0.00
Checkpoint Therapeutics (CKPT) United States $0.220B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
Synlogic (SYBX) United States $0.215B 0.00
VTv Therapeutics (VTVT) United States $0.202B 0.00
TELA Bio (TELA) United States $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.195B 0.00
Biofrontera AG (BFRA) Germany $0.193B 0.00
X4 Pharmaceuticals (XFOR) United States $0.189B 0.00
Applied Genetic Technologies (AGTC) United States $0.186B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.182B 4.68
VolitionRX (VNRX) United States $0.180B 0.00
PHASEBIO PHARMA (PHAS) United States $0.179B 0.00
ObsEva SA (OBSV) Switzerland $0.172B 0.00
Galena Biopharma (SLS) United States $0.172B 0.00
Abeona Therapeutics (ABEO) United States $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.163B 0.00
Eton Pharmaceuticals (ETON) United States $0.158B 0.00
Antibe Therapeutics (ATBPF) Canada $0.156B 0.00
DiaMedica Therapeutics (DMAC) United States $0.151B 0.00
Exicure (XCUR) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 42.86
Eyenovia (EYEN) United States $0.138B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
LogicBio Therapeutics (LOGC) United States $0.137B 0.00
Novogen (KZIA) Australia $0.136B 0.00
Catalyst Biosciences (CBIO) United States $0.136B 0.00
Yumanity Therapeutics (YMTX) United States $0.135B 0.00
Erytech Pharma SA (ERYP) France $0.133B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.133B 0.00
Aptevo Therapeutics (APVO) United States $0.131B 0.00
Longeveron (LGVN) United States $0.130B 0.00
Palatin Technologies (PTN) United States $0.130B 0.00
Cyclerion Therapeutics (CYCN) United States $0.129B 0.00
Pluristem Therapeutics (PSTI) Israel $0.128B 0.00
Aytu BioPharma (AYTU) United States $0.128B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.127B 0.00
Liminal BioSciences (LMNL) Canada $0.125B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.124B 0.00
Orgenesis (ORGS) United States $0.121B 246.50
Beyond Air (XAIR) United States $0.116B 0.00
Celsion (CLSN) United States $0.114B 0.00
Vyant Bio (VYNT) United States $0.114B 0.00
Evofem Biosciences (EVFM) United States $0.114B 0.00
Vascular Biogenics (VBLT) Israel $0.110B 0.00
CytRx (CYTR) United States $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.105B 0.00
Zosano Pharma (ZSAN) United States $0.104B 0.00
Leap Therapeutics (LPTX) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
TRACON Pharmaceuticals (TCON) United States $0.099B 0.00
Entera Bio (ENTX) Israel $0.099B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.093B 0.00
Protalix BioTherapeutics (PLX) Israel $0.092B 0.00
Evogene (EVGN) Israel $0.092B 0.00
Lumos Pharma (LUMO) United States $0.091B 0.00
AIkido Pharma (AIKI) United States $0.090B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.087B 0.00
BioCardia (BCDA) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Cleveland BioLabs (CBLI) United States $0.078B 0.00
ATyr Pharma (LIFE) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
ARIDIS PHARMACT (ARDS) United States $0.077B 0.00
Celyad SA (CYAD) Belgium $0.076B 0.00
Edesa Biotech (EDSA) Canada $0.074B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Viridian Therapeutics (VRDN) United States $0.073B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Cyclo Therapeutics (CYTH) United States $0.065B 0.00
Genetic Technologies (GENE) Australia $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Windtree Therapeutics (WINT) United States $0.061B 0.00
Pulmatrix (PULM) United States $0.060B 0.00
AEterna Zentaris (AEZS) United States $0.059B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.059B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Soligenix (SNGX) United States $0.048B 0.00
Enveric Biosciences (ENVB) United States $0.048B 0.00
Timber Pharmaceuticals (TMBR) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.94
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00